Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000588458 | SCV000698627 | uncertain significance | not provided | 2016-04-12 | criteria provided, single submitter | clinical testing | Variant summary: The SOS1 c.2945G>A variant affects a non-conserved nucleotide, resulting in an amino acid change from Arg to Gln. 4/5 in-silico tools predict this variant to be benign. This variant was not found in approximately 121264 control chromosomes from the large and broad populations of ExAC. The variant of interest has not, to our knowledge, been reported in affected individuals via publications and/or reputable databases/clinical laboratories, nor evaluated for functional impact by in vivo/vitro studies. Because of the absence of clinical information and the lack of functional studies, the variant has currently been classified as a variant of uncertain significance (VUS) until additional information becomes available. |
Labcorp Genetics |
RCV001860138 | SCV002262901 | uncertain significance | RASopathy | 2022-11-22 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SOS1 protein function. ClinVar contains an entry for this variant (Variation ID: 496301). This missense change has been observed in individual(s) with clinical features of Noonan syndrome (PMID: 29907801). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 982 of the SOS1 protein (p.Arg982Gln). |
Genome- |
RCV002467908 | SCV002763257 | uncertain significance | Noonan syndrome 4 | criteria provided, single submitter | clinical testing | ||
Genome- |
RCV002467907 | SCV002763258 | uncertain significance | Fibromatosis, gingival, 1 | criteria provided, single submitter | clinical testing |